-
Mashup Score: 3FDA Accepts NDA for Avatrombopag in Pediatric Thrombocytopenia - 7 hour(s) ago
Results from the phase 3 AVA-PED-301 trial support the FDA decision for avatrombopag in pediatric thrombocytopenia.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Pimicotinib Significantly Improves Responses Vs Placebo in TGCT - 1 month(s) ago
Treatment with pimicotinib also yields meaningful improvements in stiffness and pain symptoms among patients with TGCT in the phase 3 MANEUVER study.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet-
At 25 weeks, the ORR was 54.0% with pimicotinib vs 3.2% with placebo, representing a significant improvement in response (P <.0001). #MedTwitter #oncology | https://t.co/kVa8gzR1QX
-
-
Mashup Score: 1
Patients who start smoking cessation treatment after cancer diagnosis are found to have higher rates of survival.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet-
Survival over 15 years was higher for patients who quit smoking within 3 months (aHR, 0.75; 95% CI, 0.67-0.83), 6 months (aHR, 0.79; 95% CI, 0.71-0.88), and 9 months (aHR, 0.85; 95% CI, 0.76-0.95). #MedTwitter #oncology https://t.co/aDNv6l31YJ
-
-
Mashup Score: 12Overview of the ADRIATIC Study - 1 month(s) ago
Panelists provide an overview of the ADRIATIC study, highlighting its objectives, design, and significant results in the context of chronic spontaneous urticaria management.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
Panelists highlight the objectives, design, and key results of the ADRIATIC study. Discover its implications for patient care! @OncBrothers @StephenVLiu | #medtwitter #oncology https://t.co/onl14Ah8q1
-
-
Mashup Score: 1Bringing Bispecific Antibody Therapy to Community Oncology Centers - 2 month(s) ago
In an interview with Targeted Oncology, Courtney Van Houzen, PharmD, shared her experience in bringing bispecific antibody treatments to a community setting.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
Courtney Van Houzen, PharmD, shared her experience in bringing bispecific antibody treatments to a community setting. #MedTwitter #oncology https://t.co/95y6pFCwgR https://t.co/PGElySFyCd
-
-
Mashup Score: 0
Data presented from a pilot study evaluating HERC validated its usability in measuring equitable practices at leading cancer centers.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet-
“Studies clearly show that unequal experiences and opportunities in cancer care result in worse outcomes and shorter life-expectancies for people in underserved communities,” Taneal D. Carter, MS, MPA. #MedTwitter #Oncology https://t.co/voJOIJFtkZ
-
-
Mashup Score: 0One - Cancer Network - 2 month(s) ago
To access the requested content, please tell us a bit more about yourself. * By submitting my information, I signify my acceptance of the Terms and Conditions and Privacy Policy …
Source: one.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet-
Read about how to best approach end-of-life discussions, what they entail, and how all providers on the multidisciplinary team should be informed. #MedTwitter #oncology | @MayoClinic https://t.co/blvhdCFJVq https://t.co/2E54okFGsW
-
-
Mashup Score: 0
Findings from 3 studies combining birth and cancer registers showed postponing childbearing partially correlated with cancer increases in pregnant women.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists1Tweet-
Pregnancy-associated cancer rates increased by age, with women ages 15 to 19 at the lowest for PACs (5.3 cases per 100,000) and women ages 40 to 44 at the highest risk (63.5 cases per 100,000). #MedTwitter #oncology https://t.co/fHT9QZC3Fg
-
-
Mashup Score: 1Bringing Bispecific Antibody Therapy to Community Oncology Centers - 2 month(s) ago
In an interview with Targeted Oncology, Courtney Van Houzen, PharmD, shared her experience in bringing bispecific antibody treatments to a community setting.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
Courtney Van Houzen, PharmD, shared her experience in bringing bispecific antibody treatments to a community setting. #MedTwitter #oncology https://t.co/95y6pFCwgR https://t.co/PGElySFyCd
-
-
Mashup Score: 14Overview of the ADRIATIC Study - 2 month(s) ago
Panelists provide an overview of the ADRIATIC study, highlighting its objectives, design, and significant results in the context of chronic spontaneous urticaria management.
Source: www.targetedonc.comCategories: General Medicine News, Oncologists1Tweet-
Panelists highlight the objectives, design, and key results of the ADRIATIC study. Discover its implications for patient care! @OncBrothers @StephenVLiu | #medtwitter #oncology https://t.co/onl14Ah8q1
-
The FDA has accepted a new drug application for avatrombopag as a treatment for pediatric patients 1 year or older with persistent or chronic immune thrombocytopenia who did not experience a response with prior therapy. #MedTwitter #oncology https://t.co/guRnVgMRWZ